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Over the years there have been many attempts to define the different ages of man. 
One can think of the different problems associated with haemophilia and come up 
with the problems associated with the different ages of a person with haemophilia 
(PWH). The first age is childhood, the second adulthood, the third age is the period 
after retirement whilst for some individuals there is a fourth age of partial or full 
dependency. In childhood the problems of haemophilia include the diagnosis, 
introduction of treatment, prophylaxis in severe and some moderate individuals, 
dealing with inhibitors in previously untreated patients, compliance with prophylaxis 
and schooling. In adulthood the problems will depend on whether the PWH grew up 
with prophylaxis where almost normal health is possible or whether they grew up in 
the on demand era when joint disease is invariable with, in many persons, HIV 
and/or HCV infection. 
 
This editorial was conceived when on a single day we dealt through our haemophilia 
centre with inherited bleeding disorder patients and the following problems: 
dementia, confusion, falls, visual impairment, use of antiplatelet drugs following 
coronary artery stenting, atrial fibrillation, stroke, hypertension, renal impairment, 
advanced arthropathy as well as acquired haemophilia in an individual with 
congenital haemophilia. As haemophilia professionals we now infrequently have to 
advise or treat severe PWH with concentrates outside the setting of surgery. In 
practice, all our severe and many moderate PWH have their concentrates delivered 
to their home by a third party, are able to self infuse, and so rarely trouble the 
haemophilia centre for advice on how to treat new bleeds. The result is that much of 
our time is now devoted to managing comorbidities associated with chronic joint 
damage, chronic infections and the problems of older age. 
 
As individuals get older the risk factors for cardiovascular disease such as 
hypertension, obesity and diabetes mellitus become more prevalent(1). These 
factors are at least as frequent in PWH as in the general population but despite 
these, the risk of death from a myocardial infarction or stroke is less. Since the rate 
of atherosclerosis is the same, it is believed that the reduced cardiovascular death 
rate is due to smaller thrombi forming over ruptured atherosclerotic plaques(2). Two 
additional cardiovascular problems seen at increasing frequency are atrial fibrillation 
and acute coronary syndrome / angina where the problem is less about the acute 
management than the long term use of anticoagulant and antiplatelet medications 
(3). 
 
Orthopaedic problems are a frequent feature of many adult PWH but two additional 
problems are encountered with increasing frequency in this age group, osteoarthritis 
and redo joint replacements. Osteoarthritis can affect almost any joint and 
replacement of these joints is more common. In practice there is no real difference 
in terms of the haemophilia management of a PWH having a joint replaced for 
haemophilic or osteoarthitic arthropathy. When joints initially started being replaced 
in PWH it was felt that patients may not survive long enough to need them to be 
redone. It is now fairly common to have patients requiring replaced joints to be 
redone with no obvious upper age limit. We have a 96 year old severe haemophilia A 
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patient attending our centre in whom we performed redo knee joint replacement 
surgery at the age of 92 years; he had that joint first replaced 20 years earlier.  
 
In addition to the physical disability associated with haemophilic arthropathy, 
chronic pain and reduced muscle bulk may lead to increasingly abnormal gait which 
in turn leads to an increased risk of falls and secondary injury (4). The increased risk 
of reduced bone mineral density in PWH also raises the chance of fractures occuring 
secondary to falls. 
 
The ageing PWH can experience difficulties in gaining venous access through 
numerous factors. Multiple venepuncture attempts may heighten patient anxiety 
and suffering, delay vital treatment and increase costs. PWH may switch back to on 
demand regimes in preference over prophylaxis in the hope of reducing the 
requirement to access veins. Small, fragile or hidden veins can lead to difficulties, 
and collapsed veins due to dehydration are especially problematic. In addition, 
reduced visual acuity and depth perception, reduced manual dexterity and 
coordination may all contribute to reduced independence with clotting factor 
concentrate administration. 
 
The PWH who needs to retire early through ill health may feel the loss of a sense of 
purpose and wellbeing that an individual gains from everyday contact with work 
colleagues. The reduction in the wider social network can lead to a refocus on family 
relationships. In adulthood, the focus of the family network is an individual's partner, 
and ultimately their children. The effect of the loss of spouse, family and friends 
through bereavement or ill health has a specific and significant impact on an 
individual's personal network. Psychological problems such as dementia and 
depression require the support and dedication of a close family network. Bereaved 
individuals, childless people, unmarried and those who live alone may be at 
particular need of additional support. 
 
As age advances and patients enter the fourth age of dependency some specific 
problems can arise as some residential homes refuse to accept individuals who may 
require intravenous concentrate infusions or who are chronically infected with HIV 
or hepatitis C. It is sometimes necessary to commence prophylaxis as individuals 
depend on nursing home personnel that are unable to give on demand intravenous 
injections. 
 
In this article we may have given the impression that there is clear separation 
between the different ages but this is often not the case. The end of the first age was 
traditionally the end of the teenage years but in many Western countries it is now 
increasingly the age of going to University, leaving home or gaining first full 
employment. Although we suggested that the third age starts on retirement this 
happens at different ages in different countries and within a country varies between 
individuals and over time. The idea is that this occurs around the 60-65 year mark as 
older age comorbidities begin or start to increase at this age. Haemophilia care is no 
longer about treating bleeds but rather about treating the individual as a whole with 
all their accumulating medical comorbidities.  
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Table 1: Some of the issues at the different ages of a person with haemophilia 
 
First age: Childhood 
Diagnosis 
Introduction of treatment 
Prophylaxis 
Inhibitors 
Adherence to treatment 
Schooling and sport 
 
Second age: Adulthood 
Arthropathy 
HIV and HCV coinfection 
Prophylaxis 
Inhibitors in some patients 
 
Third age: Retirement 
Cardiovascular disease 
Renal disease 
Hypertension, obesity, diabetes 
Increasing tendency to falls 
Decreasing visual acuity 
Dementia 
Malignancy  
HIV and HCV coinfections 
Mobility 
Arthropathy 
Bone health 
Loss of social network 
 
Fourth age: Dependency 
As in third age but worse 
Seeking care/support outside the home or hospital 
 
 
